McHale Duncan

Chief Medical Officer at Evelo Biosciences, Inc.

Sold, on record
$45k
Dollars the filings state
Form 4 sales
4
Latest Nov 8, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Evelo Biosciences, Inc.Routine
    May 8, 2023 2023

    Sold 66,730 shares at $0.13 ($9k)

    McHale Duncan, Chief Medical Officer

    10b5-1 planSold 40.6% of holdings ($21k position)97,516 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Evelo Biosciences, Inc.Routine
    Aug 8, 2023 +92 days

    Sold 3,434 shares at $9.51 ($33k)

    McHale Duncan, Chief Medical Officer

    10b5-1 planSold 30.2% of holdings ($108k position)7,941 shares leftFiling

  3. 3 Form 4 sale Evelo Biosciences, Inc.Routine
    Nov 2, 2023 +86 days

    Sold 6,854 shares at $0.33 ($2k)

    McHale Duncan, Chief Medical Officer

    10b5-1 planSold 33.5% of holdings ($7k position)13,587 shares leftFiling

  4. 4 Form 4 sale Evelo Biosciences, Inc.Routine
    Nov 8, 2023 +6 days

    Sold 3,103 shares at $0.33 ($1k)

    McHale Duncan, Chief Medical Officer

    10b5-1 planSold 15.4% of holdings ($7k position)16,984 shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by McHale Duncan
Source
Nov 8, 2023Nov 8, 2023Evelo Biosciences, Inc.Chief Medical OfficerForm 4 sale3,103$1k15.4%RoutineSEC
Nov 2, 2023Nov 3, 2023Evelo Biosciences, Inc.Chief Medical OfficerForm 4 sale6,854$2k33.5%RoutineSEC
Aug 8, 2023Aug 9, 2023Evelo Biosciences, Inc.Chief Medical OfficerForm 4 sale3,434$33k30.2%RoutineSEC
May 8, 2023May 10, 2023Evelo Biosciences, Inc.Chief Medical OfficerForm 4 sale66,730$9k40.6%RoutineSEC